Bactiguard enters new partnership for Switzerland
Bactiguard has entered a new partnership with Euromed Swiss AG (Euromed), a leading, specialized Swiss distributor of medical devices. Euromed will be distributing the entire Bactiguard product portfolio for infection prevention in Switzerland.
"By working with Euromed and their experienced, professional team, we will increase the pace of our European market expansion. Euromed is a leading provider of medical devices to both public and private hospitals and we are convinced that they have the competence and the resources needed to offer advanced solutions and drive Bactiguard's sales in Switzerland,” says Jonas Östregård, SVP Sales & Marketing at Bactiguard.
"Euromed has a strong focus on innovative technology and specializes in, among other things, vascular applications, where we work close to the intensive care units. Reducing healthcare associated infections and preventing antibiotic resistance are high on the agenda within Swiss healthcare. Bactiguard's innovative, infection preventive solution saves lives, protects vulnerable patients and shortens their hospital stay. Therefore, we are very happy about this new partnership,” says Reinhold Eder, Member of the Board at Euromed.
The collaboration is based on an exclusive distribution agreement for the entire Bactiguard infection prevention BIP portfolio, with products for the urinary tract, the blood stream and respiratory tract, and covers Switzerland.
For further information, please contact:
Cecilia Edström, CFO, mobile: +46 72 226 23 28
Reinhold Eder, Member of the Board, Euromed Swiss AG, mobile: +41 79 207 82 72
About Euromed Swiss AG
1996 – EUROMED Swiss AG founded to handle the Swiss market. Today, the company is regarded as an established supplier in Switzerland, active in the fields of cardiac, thoracic and general surgery as well in interventional cardiology, interventional radiology and intensive care medicine.
Read more www.euromed.ch
Bactiguard is a Swedish medical device company with a mission to save lives. To achieve this mission we develop and supply infection protection solutions which reduce the risk of healthcare associated infections and the use of antibiotics. This way, we save significant costs for healthcare and the society at large.
The Bactiguard technology prevents bacterial adhesion and biofilm formation on medical devices. Bactiguard offers the technology through licence agreements and our BIP (Bactiguard Infection Protection) portfolio of products. Through our licence partner BD, urinary catheters with Bactiguard’s coating are market leading in the USA and Japan. Bactiguard’s own product portfolio of urinary catheters, endotracheal tubes and central venous catheters prevent some of the most common infections, which appear in the urinary tract, the blood stream and the respiratory tract.
Bactiguard is in a strong expansion phase in the European markets, China, India and the Middle East as well by establishing license agreements in new therapeutic areas. The company has about 70 employees around the world. Its headquarters and one of two production facilities are located in Stockholm, the other one in Malaysia. Bactiguard is listed on Nasdaq Stockholm.
Read more about how Bactiguard saves lives on www.bactiguard.com